Scientific breakthrough: promising new target for immunotherapy
Following the 2018 Nobel Prize for Medicine, global attention is now more than ever turned toward the promise of...
Safe cannabis pain relief without the “high”
In the wake of cannabis legalization, a team of scientists at the Research Institute of the McGill University Health Centre (MUHC) and McGill...
Cannabis and brain development
Dr. Gabriella Gobbi, psychiatrist and researcher from the Brain Repair and Integrative Neuroscience Program (BRaIN) at...
Young Canadians face heightened crash risk after consuming cannabis, new study finds
Young Canadians are more at risk of a vehicle crash even five hours after inhaling cannabis, according to results of a clinical trial...
No-Nonsense Approach to Genetic Kidney Disease in Children
The Research Institute of the McGill University Health Centre’s (RI-MUHC) push to treat a rare genetic disease in children...
A world first in interventional cardiology at the MUHC: a “jackhammer” to heal the heart
Calcium that builds and blocks the arteries of the heart is the sworn enemy of interventional cardiologists (doctors specialized in...
New means to fight 'un-killable' bacteria in healthcare settings
Scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) have identified new means of fighting drug-tolerant...
Life-saving epinephrine underused during anaphylaxis outside of hospital, study finds
Fewer than half of adults and children experiencing food-induced anaphylaxis use their epinephrine autoinjector (EAI) before being...
Preterm birth: The "Nodal" gene under the microscope
Preterm birth is a major global public health problem. Every year, 15 million babies are born prematurely and many will suffer from...
The Government of Quebec Grants $500,000 to McGill University and RI-MUHC to Support Two Collaborative Projects
The Government of Québec has awarded a total of $500,000 in funding to the McGill University and the Research Institute of the McGill...